ImpediMed Limited is a medical software technology company that specializes in the development, manufacturing, and selling of bioimpedance spectroscopy (BIS) devices and software services. With a presence in Australia, North America, and globally, the company offers SOZO, a noninvasive BIS device for assessing lymphedema and monitoring fluid status in heart failure patients. Additionally, ImpediMed provides SFB7, a single-channel, tetrapolar BIS device that analyzes body composition in healthy individuals, and ImpediVET, a veterinary application for measuring fluid status and tissue composition. The company's clientele comprises hospitals and clinics worldwide. ImpediMed Limited was established in 1999 and is headquartered in Pinkenba, Australia.